Biotechnology stocks are never short on volatility and today was no different as markets turned lower and biotech stocks were particularly hard hit.
The Nasdaq Biotechnology Index ETF (IBB -0.20%) dropped more than 2% as investors embraced safety and avoided risk. But while the 2% drop in the industry ETF was noteworthy, the move pales in comparison to the losses and gains posted by these three stocks.
Zogenix (ZGNX) and bluebird bio (BLUE -4.91%) sunk by 12% and 8%, respectively. And TherapeuticsMD (TXMD 2.13%) surged over 30% higher.
In the following slideshow, you'll learn what's behind the massive moves in these three stocks and see if I think any offer an investing angle worth considering.
